Table:
begin	end	state
1	251	cytoplasmic
252	278	transmembrane
279	289	non-cytoplasmic
290	313	transmembrane
314	324	cytoplasmic
325	351	transmembrane
352	370	non-cytoplasmic
371	391	transmembrane
392	409	cytoplasmic
410	429	transmembrane
430	451	non-cytoplasmic
452	475	transmembrane
476	486	cytoplasmic
487	507	transmembrane
508	512	non-cytoplasmic
513	533	transmembrane
534	543	cytoplasmic
544	574	transmembrane
575	587	non-cytoplasmic

Input:
>GFF3783
MNLIIVTACPQGVATRFLAARALERAANRRGWSVTTDTRGPDGKTDNKPSEAAIQQADLV
IAAVGIPVNLDVYAGKRLLQIPVTAALPDPDAILTRAQAEATPWDPAMASQESIATSTAV
GSTSAGKRIVAVTACPTGVAHTFMAAEALTAAAQSAGHKIRVETQGSVGAQDPLTEEEIA
AADVVILACDIEVDPGRFSGKRVWRTSTGAALKKPADTIRDALEQAVVLNAGQKKTSGAS
GSGEKKGPYKHLLTGVSFMLPMVVAGGLLIALSFVFGIEAFQEEGTLAAALMQIGGGTAF
KLMIPLLAGYIAWSIADRPGLAPGMIGGFLAGELGAGFLGGIVAGFLAGYVARFISQKLP
MPESIESLKPILIIPLLASLVTGLGMIYVIGEPMAAIMGALTGFLEGMGTTNAILLGGIL
GAMMCFDLGGPVNKAAYTFGVGLLSEGSGGSAPMAAIMAAGMVPAIGMGVASFIARRKFA
EAERQAGRASFVLGLCFISEGAIPFMAKDPLRVIPVCMIGGAITGALSMLFTVKLMAPHG
GLFVLAIPNAVSAVLPYLIAIAVGSLVIGFGYALLKTGKAEVTAAVS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server